-
IGMS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
IGM Biosciences (IGMS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 43.07 mm | 43.07 mm | 43.07 mm | 43.07 mm | 43.07 mm | 43.07 mm |
Cash burn (monthly) | 8.07 mm | 11.03 mm | 21.46 mm | 19.56 mm | 12.80 mm | 13.85 mm |
Cash used (since last report) | 40.99 mm | 56.04 mm | 109.06 mm | 99.39 mm | 65.02 mm | 70.37 mm |
Cash remaining | 2.08 mm | -12.98 mm | -65.99 mm | -56.33 mm | -21.95 mm | -27.30 mm |
Runway (months of cash) | 0.3 | -1.2 | -3.1 | -2.9 | -1.7 | -2.0 |
13F holders | Current |
---|---|
Total holders | 87 |
Opened positions | 16 |
Closed positions | 5 |
Increased positions | 27 |
Reduced positions | 18 |
13F shares | Current |
---|---|
Total value | 109.99 bn |
Total shares | 38.51 mm |
Total puts | 36.70 k |
Total calls | 61.30 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Haldor Topsoe Holding A/S | 10.40 mm | $93.81 mm |
Baker Bros. Advisors | 4.09 mm | $25.02 bn |
T. Rowe Price | 3.57 mm | $21.81 mm |
Siren, L.L.C. | 3.33 mm | $20.35 bn |
Invus Global Management | 3.33 mm | $40.30 mm |
Artal International S.C.A. | 3.10 mm | $0.00 |
Redmile | 2.95 mm | $18.04 bn |
SNY Sanofi | 1.44 mm | $8.79 bn |
BlackRock | 1.05 mm | $6.44 bn |
GS The Goldman Sachs Group, Inc. | 978.49 k | $5.98 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jan 25 | Steven Weber | Common Stock | Sell | Dispose S | No | No | 1.6999 | 1,122 | 1.91 k | 30,582 |
31 Dec 24 | Redmile | Common Stock | Grant | Acquire A | Yes | No | 0 | 1,734 | 0.00 | 2,963,187 |
31 Dec 24 | Lee Michael Stewart | Common Stock | Grant | Acquire A | No | No | 0 | 1,734 | 0.00 | 11,056 |
31 Dec 24 | Baker Bros. Advisors | Common Stock | Grant | Acquire A | Yes | No | 0 | 1,994 | 0.00 | 3,761,456 |
31 Dec 24 | Baker Bros. Advisors | Common Stock | Grant | Acquire A | Yes | No | 0 | 1,994 | 0.00 | 355,142 |
31 Dec 24 | M Kathleen Behrens | Common Stock | Grant | Acquire A | No | No | 0 | 3,078 | 0.00 | 19,280 |